Oracle Introduces Oracle Health Sciences Mobile Clinical Research Associate
New Mobile Application Helps Clinical Research Associates Improve Efficiency, Optimize Clinical Development Process
Oracle Health Sciences today introduced Oracle Health Sciences Mobile Clinical Research Associate, which uses the power of mobile applications to help life sciences organizations compress clinical study cycle times and reduce costs by improving site monitoring efficiency and clinical research associate (CRA) productivity.
The mobile app, designed specifically for field use, is integrated with Oracle’s Siebel Clinical Trial Management System and Oracle Health Sciences Clinical Development Analytics to provide CRAs with real-time access to essential clinical trial information, decision support data, and comprehensive trip reports in either offline or connected modes.
Site-at-a-glance capabilities provide study site performance indicators in a single view so CRAs have up-to-date site progress information at their fingertips, enabling more efficient, proactive planning and more productive site visits.
Study and site alerts notify CRAs of key milestones, activities and potential problems for the study sites they are monitoring, enabling them to respond quickly to emerging issues.
The solution’s study site check-in feature automatically captures traveling CRAs’ site check-in details via geo-location capabilities and incorporates the information into the trip report, streamlining documentation for regulatory compliance.
Oracle Health Sciences Mobile Clinical Research Associate runs natively on iOS and is now available for Apple iPhone or Apple iPad via the Apple iTunes Store.
“With the increased pressure to reduce the time and cost of clinical trials, organizations need to optimize efficiency at every level. Unfortunately, despite the labor-intensive and critical role CRAs perform, most are still using traditional and antiquated tools to do their job. Oracle Health Sciences Mobile Clinical Research Associate is designed specifically to help CRAs improve productivity and lighten their load by enabling them to manage their responsibilities using a single mobile device,” said Neil de Crescenzo, senior vice president and general manager, Oracle Health Sciences.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
